BI
Bioasis Technologies Inc.
BIOAF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $11.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.30x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 70.18%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 7,846.50%
Op. margin 12,784.50%
FCF margin 9,636.86%
Quality
0 /100
Poor ROA 130.64%
Asset turnover 0.02x
ROIC 621.16%
Debt
54 /100
Moderate Int. coverage -5.50x
Net debt/EBITDA -0.05x
Current ratio 0.70x
Stability
4 /100
Unstable Rev. volatility 376.29%
EPS volatility 324.98%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Deborah Ann Rathjen
Employees
4
Headquarters
New Haven
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report